Related Experiment Video

Updated: Jun 27, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
11:35

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

Molecular Epidemiology of Pseudomonas aeruginosa in the Intensive Care Units - A Review

D S Blanc1, P Francioli, G Zanetti

  • 1Hospital Preventive Medicine, University Hospital of Lausanne, Switzerland.

The Open Microbiology Journal
|December 18, 2008
PubMed

Insights

Pseudomonas aeruginosa is a major cause of hospital infections. Identifying its sources and transmission routes in intensive care units (ICUs) is crucial for effective control.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Pseudomonas aeruginosa is a significant nosocomial pathogen, frequently found in intensive care units (ICUs).
  • This opportunistic bacterium colonizes a notable percentage of hospitalized patients and thrives in moist environments.
  • Understanding its reservoirs and transmission is vital for infection control.

Purpose of the Study:

  • To review recent literature on identifying reservoirs and transmission modes of Pseudomonas aeruginosa in ICUs.
  • To analyze the role of endogenous versus exogenous sources of P. aeruginosa infections.
  • To inform strategies for mitigating P. aeruginosa transmission in healthcare settings.

Main Methods:

  • Literature review of studies employing highly discriminatory typing methods.
  • Analysis of identified reservoirs (endogenous flora vs. exogenous sources).
  • Evaluation of factors influencing transmission rates.

Main Results:

  • The endogenous flora is often the primary source of P. aeruginosa infections in ICUs, though exogenous sources also contribute.
  • Transmission dynamics can vary significantly between different ICU settings.
  • Factors such as healthcare worker compliance and environmental contamination influence infection rates.

Conclusions:

  • Eradicating P. aeruginosa reservoirs is challenging due to its ubiquity and colonization rates.
  • Reinforcing infection control measures is the most effective strategy to limit P. aeruginosa transmission in ICUs.
  • Further research may be needed to understand setting-specific variations in transmission.
Keywords:
Pseudomonas aeruginosaintensive care unitmolecular epidemiology

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...